Molecular Imaging News and Research

RSS

SNM Clinical Trials Network Workshop: Experts to discuss usage of molecular imaging

On Feb. 2, the final day of the second annual SNM Clinical Trials Network Workshop, experts working in various facets of the molecular imaging community met in Albuquerque, N.M., to discuss the nuts and bolts of using imaging in clinical trials and the challenges and opportunities ahead in the regulatory landscape.

3 Feb 2010

SNM's Nanomedicine and Molecular Imaging Summit examines the use of nanoparticles

SNM's Nanomedicine and Molecular Imaging Summit wrapped up today in Albuquerque, N.M., with in-depth discussion-and a high sense of energy looking ahead.

3 Feb 2010

Summit explores medical application of molecular nanotechnology

Albuquerque's blue skies and majestic mountains provided a scenic backdrop for a summit that explores one of the most promising technologies on the horizon--nanomedicine, or the medical application of molecular nanotechnology--a still-developing science dedicated to constructing microscopic probes and biomechanical devices.

2 Feb 2010

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Published reports on the usefulness of CT scans for complicated H1N1 cases have spurred use of these procedures in U.S. hospitals. According to healthcare market research publisher Kalorama Information, this opens up a pathway of diagnostics for physicians and overall is a positive sign not only for the technology but also for companies making chemical agents for procedures.

29 Jan 2010

NNSA awards $9M for B&W TSG's medical isotope production program

Babcock & Wilcox Technical Services Group, Inc. has been awarded approximately $9 million from the National Nuclear Security Administration (NNSA) for the company’s medical isotope production program. Awarded under a cooperative agreement, the funding will be used for further development of B&W TSG’s patented reactor technology for medical isotope production using low enriched uranium. B&W TSG is an operating unit of The Babcock & Wilcox Company.

27 Jan 2010

Molecular image guided system for diagnosis and treatment of small-cell peripheral lung cancer

Scientists at The Methodist Hospital Research Institute in Houston received a research grant from the Cancer Prevention Research Institute of Texas (CPRIT) today to develop the first molecular image guided system to diagnose and treat small-cell peripheral lung cancer in one sitting.

22 Jan 2010

Growth of OMI equipment sales to reach $400M in 2014

In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.

21 Jan 2010

Positron's Attrius PET scanner sold to Gramercy Cardiac Diagnostic Services

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced today the sale of its AttriusTM PET scanner to Manhattan based, Gramercy Cardiac Diagnostic Services, owned by prominent New York City cardiologist, Dr. Peter Rentrop.

21 Jan 2010

Copper-free version of click chemistry crafted to create biomolecular probes

For the first time, the widely used molecular synthesis technique known as click chemistry has been safely applied to a living organism. Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have crafted a unique copper-free version of click chemistry to create biomolecular probes for in vivo studies of live mice. Conventional click chemistry reactions require a copper catalyst that is toxic to cells and organisms.

20 Jan 2010

DSG teams up with pharmaceutical technology company to speed early detection of major diseases

DSG, a leader in electronic data capture (EDC) has teamed up with a leading-edge pharmaceutical technology company to speed the early detection of Alzheimer’s, Parkinson’s, and Diabetes.

12 Jan 2010

Educational sessions and special workshops highlight advancements in molecular imaging

SNM's Conjoint Mid-Winter Meetings, Jan. 27-Feb. 2, 2010, in Albuquerque, N.M., will bring together four scientific meetings under one umbrella. The meeting, which provides attendees with the opportunity to earn up to 25 continuing education credits, will highlight the latest advancements in molecular imaging and nuclear medicine. The educational sessions will conclude with special workshops on nanomedicine and clinical trials.

7 Jan 2010

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

29 Dec 2009

Planet Green to be acquired by IMAGIN Molecular

IMAGIN Molecular Corporation (OTCBB: IMGM) has agreed in a letter of intent to issue 49% of the post capitalization of IMGM in exchange for 84,000,000 Positron Corporation common shares plus 100% of the equity of the Planet Green Bottle, all IMGM shares to be distributed to shareholders or affiliates of Planet Green.

24 Dec 2009

U.S. Congress approves $1.6 million for AdMeTech Foundation's research program

AdMeTech Foundation, a nonprofit organization, announced today that the U.S. Congress has approved $1.6 million for funding of its groundbreaking research program aimed at developing novel imaging technologies for early prostate cancer detection, which in turn is critical for saving lives and designing customized patient care, including the most effective and the least invasive approach.

23 Dec 2009

FDA clears Dilon Diagnostics' GammaLoc lesion-localization system

Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

21 Dec 2009

Gamma Medica-Ideas signs exclusive license and commercialization agreement with Mayo Clinic

Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.

15 Dec 2009

FDA publishes cGMPs for PET drugs

The U.S. Food and Drug Administration (FDA) announced publication of a final regulation on current good manufacturing practices (cGMPs) for the production of positron emission tomography (PET) drugs, as well as a guidance document describing acceptable approaches that would enable PET drug producers to meet the requirements in the proposed regulation.

15 Dec 2009

Nanoparticle could allow diagnosis and treatment in one visit

Researchers at Rice University and Baylor College of Medicine (BCM) have created a single nanoparticle that can be tracked in real time with MRI as it homes in on cancer cells, tags them with a fluorescent dye and kills them with heat.

15 Dec 2009

Quebec Superior Court approves amended proposal filed by ART

ART Advanced Research Technologies Inc. (ART), a Canadian medical device company specializing in optical molecular imaging products for the healthcare and pharmaceutical industries, announces that the Quebec Superior Court approved today the amended proposal (the "Proposal") filed by ART under the Bankruptcy and Insolvency Act (Canada) (the "BIA").

10 Dec 2009

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide.

3 Dec 2009

Molecular Imaging News and Research

SNM Clinical Trials Network Workshop: Experts to discuss usage of molecular imaging

SNM's Nanomedicine and Molecular Imaging Summit examines the use of nanoparticles

Summit explores medical application of molecular nanotechnology

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

NNSA awards $9M for B&W TSG's medical isotope production program

Molecular image guided system for diagnosis and treatment of small-cell peripheral lung cancer

Growth of OMI equipment sales to reach $400M in 2014

Positron's Attrius PET scanner sold to Gramercy Cardiac Diagnostic Services

Copper-free version of click chemistry crafted to create biomolecular probes

DSG teams up with pharmaceutical technology company to speed early detection of major diseases

Educational sessions and special workshops highlight advancements in molecular imaging

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

Planet Green to be acquired by IMAGIN Molecular

U.S. Congress approves $1.6 million for AdMeTech Foundation's research program

FDA clears Dilon Diagnostics' GammaLoc lesion-localization system

Gamma Medica-Ideas signs exclusive license and commercialization agreement with Mayo Clinic

FDA publishes cGMPs for PET drugs

Nanoparticle could allow diagnosis and treatment in one visit

Quebec Superior Court approves amended proposal filed by ART

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News